
Why Dis-Chem Is Investing Through The Downturn
Loading player...
Dis-Chem grew revenue by 8% and continued gaining market share, but earnings came under pressure as the retailer accelerated investment in digital transformation, new stores and its healthcare ecosystem. CEO Rui Morais discusses Better Rewards, expansion plans, changing consumer behaviour and the long-term strategy underpinning the group's investment drive

